Change search
ReferencesLink to record
Permanent link

Direct link
Antibodies to mutated citrullinated vimentin (MCV) are a better predictor of disease activity at 24 months in rheumatoid arthritis than antibodies to cyclic citrullinated peptide (CCP).
2006 (English)In: Arthritis and Rheumatism, ISSN 0004-3591, E-ISSN 1529-0131, Vol. 54Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2006. Vol. 54
URN: urn:nbn:se:umu:diva-39101OAI: diva2:389236
70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, DC, NOV 10-15, 2006Available from: 2011-01-19 Created: 2011-01-18 Last updated: 2011-01-19

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Dahlqvist, Solbritt Rantapää
In the same journal
Arthritis and Rheumatism

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 18 hits
ReferencesLink to record
Permanent link

Direct link